Varian Medical Systems ( VAR) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.6%. By the end of trading, Varian Medical Systems fell $3.58 (-6.3%) to $53.73 on heavy volume. Throughout the day, 6.5 million shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 1.2 million shares. The stock ranged in price between $52.90-$55 after having opened the day at $55 as compared to the previous trading day's close of $57.31. Other company's within the Health Care sector that declined today were: Aoxing Pharmaceutical Company ( AXN), down 21.2%, Hill-Rom Holdings ( HRC), down 18.1%, StemCells ( STEM), down 13.2%, and China Pharma ( CPHI), down 11.8%.

Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy worldwide. Varian Medical Systems has a market cap of $6.21 billion and is part of the health services industry. The company has a P/E ratio of 15.9, below the average health services industry P/E ratio of 16.2 and below the S&P 500 P/E ratio of 17.7. Shares are down 14.6% year to date as of the close of trading on Wednesday. Currently there are nine analysts that rate Varian Medical Systems a buy, no analysts rate it a sell, and one rates it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the positive front, XenoPort ( XNPT), up 23.7%, Spectranetics Corporation ( SPNC), up 18%, iBio ( IBIO), up 13.2%, and Synta Pharmaceuticals ( SNTA), up 12.2%, were all gainers within the health care sector with Celgene Corporation ( CELG) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null